When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
The Trade: Tracon Pharmaceuticals, Inc. TCON Director William Larue acquired a total of 6545 shares shares at an average price of $3.82. The insider spent $25,001.90 to buy those shares.
What’s Happening: TRACON Pharmaceuticals recently announced it increased a previously announced bought deal offering of common stock to $15 million.
What Tracon Pharmaceuticals Does: TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer.
The Trade: Anixa Biosciences Inc ANIX Director Arnold M Baskies acquired a total of 19000 shares shares at an average price of $4.33. The insider spent $82,270.00 to buy those shares.
What’s Happening: Anixa Biosciences shares have jumped around 15% over the past month.
What Anixa Biosciences Does: Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer.
The Trade: Ault Global Holdings, Inc. DPW Executive Chairman Milton C. Ault III acquired a total of 10000 shares shares at an average price of $2.32. The insider spent $23,198.00 to buy those shares.
What’s Happening: DPW recently reported adjournment of annual shareholder meeting due to lack of quorum.
What Ault Global Does: Ault Global Holdings is a diversified holding company owning subsidiaries engaged in commercial and defense solutions, commercial lending and advanced textile technology.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.